Logo
Search

Rules:

Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.

Search for "safety"

Displaying results 1 to 10 out of 10

  News 4 81%
  ... for an oncological treatment Known critical cardiac safety profile according to the SMPC Clinical conduct in 6 ... of external specialists (cardiologists) for cardiac safety assesments and provison of a Data Safety Monitoring Board Adaptive trial design to combine ... IV dosing procedure to ensure tolerability and
  Size: 29 K - Created: 18-11-12 - Modified: 02-08-19 10:27
Path: /Home/News 4

  Imprint 74%
  ... Yuri Arcurs/fotolia | Julia Berlin Representative for medical device safety Health care facilities with regularly more than 20 employees must ... training is designated as a representative for medical device safety. As a central department in the health facility, the representative for medical device
  Size: 32 K - Created: 16-10-14 - Modified: 02-08-19 10:27
Path: /Contact/Imprint

  Trial Expertise 70%
  ... after last subject dosed in a particular dose group. Safety and tolerability Suitable study measures and profiles ... and clinical data on the molecule. Cardiac safety trials in healthy subjects and patients About 3–5 trials annually are cardiac safety trials. In some cases CRS cooperates with a central ... range of genotyped subjects . Thorough QTc/cardiac
  Size: 34 K - Created: 18-11-12 - Modified: 02-08-19 10:27
Path: /Expertise/Trial Expertise

  Consultancy 69%
  ... plans both in early and late-stage development Scientific advice meetings IND filing/CTA filing Integrated summaries on efficacy and safety regulatory meetings and representation End-of-Phase II meetings
  Size: 29 K - Created: 18-11-12 - Modified: 02-08-19 10:27
Path: /Services/Consultancy

  Partners 67%
  ... Forschung GmbH www.lkf-kiel.de Services Local safety lab provide & central lab services in multicentre ... Labs Mönchengladbach GmbH www.mlm-labs.com Services Safety lab provider Facts Est. 1993 Headcount: 20 ... Dr. Schmitt & Partner http://www.lab-kl.de Services Safety lab provider Facts Est 1974 Headcount: 130 ... centralised core laboratory for cardiac
  Size: 43 K - Created: 18-11-12 - Modified: 02-08-19 10:27
Path: /CRS/Partners

  In a Nutshell 62%
  ... impairment Respiratory / inhalative devices Women's health / gynaecological examinations Men's health Dermal & transdermal application Skin safety, sensitisation & photo-toxicity Opioids Large Pool of Volunteers and Patients Male & female Different age groups (incl. 85 years and over) ...
  Size: 31 K - Created: 12-08-15 - Modified: 30-09-19 19:48
Path: /CRS/In a Nutshell

  Home 62%
  ... excellent track record is based on more than four decades of experience in clinical research, and the very highest standards of quality and safety. Click  here to see our latest Press Release. Services CRS. Experts. Early Phase. First in Human to Proof of Concept in Patients. CRS is a ...
  Size: 36 K - Created: 18-11-12 - Modified: 02-08-19 10:27
Path: /Home

  2010-2019 59%
  ... targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics. Res Pract ... antibiotic: Pharmacokinetics, tolerability and safety in subjects with mild, moderate, and severe renal ... S , Berse M , Schultz A , Otto C.  Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY ... Randomised, Double-Blind, Phase I Study Investigating
  Size: 67 K - Created: 09-11-15 - Modified: 14-08-19 14:46
Path: /Expertise/Published Expertise/2010-2019

  2000 – 2009 56%
  ... on the pharmacokinetics, pharmacodynamics, and safety of tezosentan. J Clin Pharmacol 2009; 49(4):455-464. ... with monophosphoryl lipid A (MPL®): preliminary safety, efficacy and immunogenicity results. The journal of ... 2008), November 6-8, 2008, Berlin. Timmer W. Cardiac Safety – Dr Wolfgang Timmer of CRS examines the conduct of ... V, Tzatzaris M, Merkl K, Wulff N, Chaplin P.
  Size: 52 K - Created: 09-11-15 - Modified: 02-08-19 10:27
Path: /Expertise/Published Expertise/2000 – 2009

  1990 – 1999 48%
  ... Dehn A. Terfenadine induced QTc-Prolongation in healthy subjects - a safety model. Eur J Clin Pharmacol 1999 ; 55 (No. 108). Rost KL, Fuhr U, ... , Püchler K, Eckl KM, Plenker A, Möller M , Hucke HP. Cardiovascular safety of the monoaminooxidase inhibitor (MAO-I) RS-8359 in combination ... to man of the new acid pump antagonist BY841: tolerability,
  Size: 60 K - Created: 18-11-12 - Modified: 02-08-19 10:27
Path: /Expertise/Published Expertise/1990 – 1999

FooterEnd